Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neurotransmitter Reuptake Inhibitors in Mental and Physical Fatigue
NCT05880342Phase 3Recruiting
- Sponsor
- Vrije Universiteit Brussel
- Start
- May 2023
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of reboxetine, methylphenidate hydrochloride extended-release chewable tablet in fatigue, sponsored by Vrije Universiteit Brussel. Started May 2023; status: recruiting.
02
Drugs
reboxetinemethylphenidate hydrochloride extended-release chewable tablet
03
Conditions
fatigue
Beyond the preview
Go deeper on NCT05880342.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05880342.